Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedFeb 07, 2026
DataAggregated Company Financials
Companies5
  • 7D-4.3%
  • 3M-4.1%
  • 1Y1.5%
  • YTD-7.5%

Over the last 7 days, the Pharma industry has dropped 4.3%, driven by Photocure declining 5.5%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 135% per annum.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 07 Feb 2026NOK 3.5bNOK 1.6b-NOK 67,438,434.00415.9x-52x2.2x
Mon, 05 Jan 2026NOK 3.8bNOK 1.6b-NOK 67,438,434.00457.4x-56.1x2.4x
Wed, 03 Dec 2025NOK 3.3bNOK 1.6b-NOK 67,438,434.00403.2x-49x2.1x
Fri, 31 Oct 2025NOK 3.3bNOK 1.5b-NOK 90,169,434.0012.9x-36.3x2.1x
Sun, 28 Sep 2025NOK 3.3bNOK 1.5b-NOK 83,687,434.0013.5x-39x2.1x
Tue, 26 Aug 2025NOK 3.5bNOK 1.5b-NOK 121,455,434.0013.9x-28.9x2.3x
Thu, 24 Jul 2025NOK 3.5bNOK 1.5b-NOK 91,864,434.00390.9x-38.4x2.3x
Sat, 21 Jun 2025NOK 3.2bNOK 1.5b-NOK 115,163,434.00321.2x-27.6x2.1x
Mon, 19 May 2025NOK 3.2bNOK 1.5b-NOK 122,678,000.00318.9x-26x2.1x
Wed, 16 Apr 2025NOK 3.1bNOK 1.5b-NOK 129,957,000.00139.2x-23.8x2.1x
Fri, 14 Mar 2025NOK 3.1bNOK 1.5b-NOK 153,695,743.00149x-20.5x2.1x
Sun, 09 Feb 2025NOK 3.3bNOK 1.5bNOK 22.4m22x148.7x2.3x
Tue, 07 Jan 2025NOK 3.1bNOK 1.5bNOK 22.4m23x138.5x2.1x
Thu, 05 Dec 2024NOK 2.9bNOK 1.5bNOK 22.4m22.1x128.3x1.9x
Sat, 02 Nov 2024NOK 3.0bNOK 1.5bNOK 34.2m21.4x88.6x2.1x
Mon, 30 Sep 2024NOK 3.2bNOK 1.5bNOK 45.2m21.9x71.6x2.2x
Wed, 28 Aug 2024NOK 2.9bNOK 1.5bNOK 105.8m20.7x27.3x1.9x
Fri, 26 Jul 2024NOK 3.0bNOK 1.5bNOK 49.7m161.5x60.1x2x
Sun, 23 Jun 2024NOK 3.3bNOK 1.5bNOK 10.2m181.6x323.6x2.2x
Tue, 21 May 2024NOK 3.2bNOK 1.5bNOK 7.6m177.3x428.5x2.2x
Thu, 18 Apr 2024NOK 3.2bNOK 1.5bNOK 7.6m154.5x421.7x2.2x
Sat, 16 Mar 2024NOK 3.2bNOK 1.5bNOK 33.1m153.3x97.1x2.2x
Mon, 12 Feb 2024NOK 3.4bNOK 1.4bNOK 18.6m25.5x183.9x2.4x
Wed, 10 Jan 2024NOK 3.7bNOK 1.4bNOK 18.6m25.3x196.9x2.6x
Fri, 08 Dec 2023NOK 3.1bNOK 1.4bNOK 18.6m23.7x168.2x2.2x
Sun, 05 Nov 2023NOK 3.3bNOK 1.4b-NOK 8,236,125.0027.6x-398.7x2.4x
Tue, 03 Oct 2023NOK 3.3bNOK 1.3b-NOK 38,433,125.0052.4x-85.1x2.4x
Thu, 31 Aug 2023NOK 2.9bNOK 1.3b-NOK 53,836,125.0049.7x-53x2.1x
Sat, 29 Jul 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0078.4x-50.1x2.4x
Mon, 26 Jun 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0071.2x-49.5x2.4x
Wed, 24 May 2023NOK 3.2bNOK 1.2b-NOK 104,503,000.0076.4x-30.7x2.6x
Fri, 21 Apr 2023NOK 3.1bNOK 1.1b-NOK 140,813,000.0022.6x-21.7x2.8x
Sun, 19 Mar 2023NOK 3.3bNOK 1.1b-NOK 140,813,000.0023.4x-23.7x3.1x
Tue, 14 Feb 2023NOK 4.6bNOK 1.0b-NOK 148,546,289.0046.3x-31.3x4.6x
Price to Earnings Ratio

-31.3x


Total Market Cap: NOK 4.6bTotal Earnings: -NOK 148,546,289.00Total Revenue: NOK 1.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 39.9x202420252026
Current Industry PE
  • Investors are relatively neutral on the Norwegian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market2.65%
Healthcare-3.18%
Pharma-4.26%
Pharma-4.26%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SOFTX SoftOx SolutionsNOK 0.06-0.7%
NOK 1.7m
71.4%PS10.8x

Latest News